5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research
References (512)
- et al.
Behavioral and biochemical effects of the 5-HT1A receptor agonists flesinoxan and 8-OH-DPAT in the rat
Eur. J. Pharmac.
(1991) - et al.
Extracellular serotonin and 5-hydroxyindoleacetic acid in hypothalamus of the unanesthetized rat measured by in vivo dialysis coupled to high-performance liquid chromatography with electrochemical detection: dialysate serotonin reflects neuronal release
Brain Res.
(1989) - et al.
The effects of umespirone as a potential anxiolytic and antipsychotic agent
Pharmac. Biochem. Behav.
(1991) - et al.
Profiles of interaction of and anxiolytic agents in a mouse model
Eur. J. Pharmac.
(1992) - et al.
The interaction of R(+)- and S(−)-zacopride with PCPA to modify rodent aversive behaviour
Eur. J. Pharmac.
(1992) - et al.
Subchronic treatment with anxiolytic doses of the 5-HT1A receptor agonist ipsapirone does not affect 5-HT2 receptor sensitivity in the rat
Eur. J. Pharmac.
(1993) - et al.
The effects of 5-HT1B characterizing agents in the elevated plus-maze
Life Sci.
(1990) - et al.
Behavioural studies on WAY 100289, a novel 5-HT3 receptor antagonist, in two animal models of anxiety
Eur. J. Pharmac.
(1992) - et al.
The effects of parachlorophenylalanine on experimentally induced conflict behavior
Pharmac. Biochem. Behav.
(1973) - et al.
Common pharmacological and physicochemical properties of 5-HT3 binding sites in the rat cerebral cortex and NG 108-15 clonal cells
Biochem. Pharmac.
(1990)
The effects of DAU 6215, a novel 5HT-3 antagonist, in animal models of anxiety
Pharmacol. Res.
(1993)
Homogeneous 5-HT1D recognition sites in the human subtantia nigra identified with a new iodinated radioligand
Eur. J. Pharmac.
(1991)
Effect of 5-HT1A agonists on stress-induced deficit in open field locomotor activity of rats: evidence that this model identifies anxiolytic-like activity
Neuropharmacology
(1989)
Stimulation of hippocampal 5-HT1A-receptors causes amnesia and anxiolytic-like but not antidepressant-like effects in the rat
Eur. J. Pharmac.
(1993)
Attenuated habituation due to parachlorophenylalanine
Pharmac. Biochem. Behav.
(1973)
Animal models of anxiety: the effect of compounds that modify serotonergic function
TIPS
(1987)
Effects of ACTH, benzodiazepines and 5-HT antagonists on escape from periaqueductal grey stimulation in the rat
Prog. Neuro-Psychopharmac. biol. Psychiat.
(1982)
Parachlorophenylalanine and habituation to repetitive auditory startle stimuli in rats
Physiol. Behav.
(1970)
Exploration of mice in a black and white test box: validation as a model of anxiety
Pharmac. Biochem. Behav.
(1989)
The effect of the 5-HT3 receptor antagonist, RS-42358-197, in animal models of anxiety
Eur. J. Pharmac.
(1993)
Brain mechanisms for offense, defense and submission
Behav. Brain Sci.
(1979)
Localization of tritiated serotonin in rat brain by electron-microscopic autoradiography
J. Pharmac. exp. Ther.
(1967)
Antagonism studies with BMY-7378 and NAN-190: effects on 8-hydroxy-2-(di-n-propylamino)tetralin-induced increases in punished responding of pigeons
J. Pharmac. exp. Ther.
(1992)
Anxiolytic effects of lisuride and its action to central 5-HT1A receptors
Folia pharmac. jap.
(1991)
Pharmacologic effects of MJ 9022-1, a potential tranquilizing agent
Arzneimittel-Forsch.
(1974)
Early life protein malnutrition changes exploration of the elevated plus-maze and reactivity to anxiolytics
Psychopharmacology
(1991)
Comparison of the anticonflict effect of buspirone and its major metabolite 1-(2-pyrimidyl)-piperazine (1-PP) in rats
Jap. J. Pharmac.
(1993)
A comparison of the anticonflict activity of serotonin agonists and antagonists in rats
Soc. Neurosci. Abstr.
(1986)
Neuropharmacology of FG5893. a new psychotropic drug with high affinity for both the 5-HT1A and the 5-HT2 serotonin receptor
Preclinical neuropharmacological profile of WY-48,723, a potent serotonin (5-HT1A) agonist
Soc. Neurosci. Abstr.
(1988)
Increased 5-HT release mediates the anxiogenic response during benzodiazepine withdrawal: a review of supporting neurochemical and behavioural evidence
Psychopharmacology
(1993)
Neurochemical correlates of behavior — II. Correlation of brain monoamine oxidase activity with behavioural changes after iproniazid and 5-hydroxytryptophan administration
J. Neurochem.
(1961)
Ritanserin an original sleep quality improving agent in generalized anxiety disorders
Mediation by serotonin of the antiaversive effect of zimelidine and propranolol injected into the dorsal midbrain central grey
J. Psychopharmac.
(1988)
Microinjection of propranolol into the dorsal periaqueductal gray causes an anxiolytic effect in the elevated plus-maze antagonized by ritanserin
Psychopharmacology
(1991)
Receptorial profiles of atypical antipsychotics at cloned human dopamine D2 and D3 receptors and at rat D2 and receptors in vitro/ex vivo
Soc. Neurosci. Abstr.
(1993)
Comparison of the effects of buspirone, diazepam, haloperidol and sulpiride on a conflict schedule in rats
Neurosci. Lett.
(1986)
Identification of 5-HT3 recognition sites in human brain tissue using [3H]zacopride
J. Pharm. Pharmac.
(1988)
Studies on the effects of 5-HT1A drugs in the pigeon
Drug Dev. Res.
(1992)
Anxiolytic effects of 5-HT1A agonists, 5-HT3 antagonists and benzodiazepines: conflict and drug discrimination studies
5-HT receptors as target for the development of novel anxiolytic drugs: models, mechanisms and future directions
Psychopharmacology
(1993)
Anticonflict and discriminative stimulus effects of the 5-HT1A compounds WY-47,846 and WY-48,723 and the mixed 5-HT1A agonist/5-HT2 antagonist WY-50,324 in pigeons
Drug Dev. Res.
(1991)
Behavioral and pharmacological analysis of the effects of buspirone
FASEB J.
(1984)
Behavioral studies with anxiolytic drugs. III. Antipunishment actions of buspirone in the pigeon do not involve benzodiazepine receptor mechanisms
J. Pharmac. exp. Ther.
(1986)
Anticonflict effects of the 5-HT1A compound flesinoxan
J. Psychopharmac.
(1989)
Attenuation of chemically induced defense response of 5-HT1 receptor agonists administered into the periaqueductal gray
Psychopharmacology
(1992)
Cyclic adenosine monophosphate phosphodiesterase in brain: effect on anxiety
Science
(1972)
Mianserin-induced 5-HT2 receptor downregulation results in anxiolytic effects in the elevated plus-maze test
Drug Dev. Res.
(1992)
The influence of psychotropic drugs on the ultrasonic calling of mouse pups
Psychopharmacology
(1988)
Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice
Br. J. Pharmac.
(1990)
Cited by (0)
- ∗
Present address—Synthélabo Recherche (L.E.R.S.), CNS Pharmacology Group, 31, avenue Paul Vaillant-Couturier, B.P. 110, 92225 Bagneux Cedex, France.
Copyright © 1995 Published by Elsevier Inc.